JP2008518914A - アセトアミノフェン、カフェインおよび所望によりアスピリンを、吸収を増強するためのアルカリ性物質と共に含む組成物 - Google Patents

アセトアミノフェン、カフェインおよび所望によりアスピリンを、吸収を増強するためのアルカリ性物質と共に含む組成物 Download PDF

Info

Publication number
JP2008518914A
JP2008518914A JP2007539060A JP2007539060A JP2008518914A JP 2008518914 A JP2008518914 A JP 2008518914A JP 2007539060 A JP2007539060 A JP 2007539060A JP 2007539060 A JP2007539060 A JP 2007539060A JP 2008518914 A JP2008518914 A JP 2008518914A
Authority
JP
Japan
Prior art keywords
composition
analgesic
antipyretic
alkaline substance
acetaminophen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007539060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518914A5 (cg-RX-API-DMAC10.html
Inventor
ロン・リュー
マイケル・コーボ
ジャティン・デサイ
ジェラード・ピー・フルンジ
キ・シャオホン
キャンディス・ワイ・チョイ
ラウル・アール・ガンディ
アテフ・ゼット・ブーロス
Original Assignee
ノバルティス アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス アクチエンゲゼルシャフト filed Critical ノバルティス アクチエンゲゼルシャフト
Publication of JP2008518914A publication Critical patent/JP2008518914A/ja
Publication of JP2008518914A5 publication Critical patent/JP2008518914A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007539060A 2004-10-28 2005-10-26 アセトアミノフェン、カフェインおよび所望によりアスピリンを、吸収を増強するためのアルカリ性物質と共に含む組成物 Pending JP2008518914A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62281204P 2004-10-28 2004-10-28
PCT/US2005/038507 WO2006049978A1 (en) 2004-10-28 2005-10-26 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption

Publications (2)

Publication Number Publication Date
JP2008518914A true JP2008518914A (ja) 2008-06-05
JP2008518914A5 JP2008518914A5 (cg-RX-API-DMAC10.html) 2008-12-04

Family

ID=35744599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007539060A Pending JP2008518914A (ja) 2004-10-28 2005-10-26 アセトアミノフェン、カフェインおよび所望によりアスピリンを、吸収を増強するためのアルカリ性物質と共に含む組成物

Country Status (17)

Country Link
US (1) US20070298096A1 (cg-RX-API-DMAC10.html)
EP (1) EP1807068B1 (cg-RX-API-DMAC10.html)
JP (1) JP2008518914A (cg-RX-API-DMAC10.html)
CN (1) CN101048155A (cg-RX-API-DMAC10.html)
AR (1) AR051145A1 (cg-RX-API-DMAC10.html)
AT (1) ATE460930T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005302618B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0520000A2 (cg-RX-API-DMAC10.html)
CA (1) CA2583517C (cg-RX-API-DMAC10.html)
DE (1) DE602005020048D1 (cg-RX-API-DMAC10.html)
MX (1) MX2007005121A (cg-RX-API-DMAC10.html)
NO (1) NO20072255L (cg-RX-API-DMAC10.html)
PE (1) PE20061125A1 (cg-RX-API-DMAC10.html)
PL (1) PL1807068T3 (cg-RX-API-DMAC10.html)
PT (1) PT1807068E (cg-RX-API-DMAC10.html)
RU (1) RU2398571C2 (cg-RX-API-DMAC10.html)
WO (1) WO2006049978A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
CN100417385C (zh) * 2006-09-26 2008-09-10 林星 一种用于治疗外伤的外用制剂
GB0707489D0 (en) * 2007-04-18 2007-05-23 Renaissance Pharma Compounds
CN101596163B (zh) * 2008-06-06 2012-06-27 康美保宁(四川)制药有限公司 阿咖酚微丸制剂及其制备方法
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method
CN102861040B (zh) * 2012-08-02 2014-04-23 广东环球制药有限公司 含有阿司匹林、对乙酰氨基酚和咖啡因的药物组合物及其制备方法
CN102949401A (zh) * 2012-09-06 2013-03-06 广东九明制药有限公司 对乙酰氨基酚、乙酰水杨酸和咖啡因组合物及其制备工艺
US10124005B1 (en) * 2017-12-15 2018-11-13 Lisa Josette Myslinski Multisymptom migraine combination medication
CN110711197B (zh) * 2018-07-12 2023-11-24 北京恒润泰生医药科技有限公司 阿司匹林和对乙酰氨基酚的分子复合物加咖啡因,其制备,活性及应用
CN108853124A (zh) * 2018-08-15 2018-11-23 康美保宁(四川)制药有限公司 一种阿咖酚制剂及其制剂方法
GB202007670D0 (en) * 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5759804A (en) * 1980-08-18 1982-04-10 Bristol Myers Co Alkalline analgesic capsule
JPH05148139A (ja) * 1991-11-29 1993-06-15 Lion Corp イブプロフエン含有解熱鎮痛剤
JPH05294829A (ja) * 1992-02-17 1993-11-09 Lion Corp イブプロフェン含有製剤
JPH06227995A (ja) * 1993-02-03 1994-08-16 Takeda Chem Ind Ltd 安定化された固型製剤
JPH07206689A (ja) * 1994-01-21 1995-08-08 Barnett Lab Ltd 治療組成物および宿酔の治療のためのこの組成物の使用法
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
JP2002012557A (ja) * 2000-06-28 2002-01-15 Lion Corp 内服薬組成物
WO2002096406A1 (en) * 2001-05-25 2002-12-05 Ssp Co., Ltd. Medicinal compositions
JP2004210750A (ja) * 2003-01-08 2004-07-29 Nitto Yakuhin Kogyo Kk 生体リズム応用キット

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
RU2101014C1 (ru) * 1995-09-07 1998-01-10 Акционерное общество "Курский комбинат лекарственных средств" Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5759804A (en) * 1980-08-18 1982-04-10 Bristol Myers Co Alkalline analgesic capsule
JPH05148139A (ja) * 1991-11-29 1993-06-15 Lion Corp イブプロフエン含有解熱鎮痛剤
JPH05294829A (ja) * 1992-02-17 1993-11-09 Lion Corp イブプロフェン含有製剤
JPH06227995A (ja) * 1993-02-03 1994-08-16 Takeda Chem Ind Ltd 安定化された固型製剤
JPH07206689A (ja) * 1994-01-21 1995-08-08 Barnett Lab Ltd 治療組成物および宿酔の治療のためのこの組成物の使用法
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
JP2002012557A (ja) * 2000-06-28 2002-01-15 Lion Corp 内服薬組成物
WO2002096406A1 (en) * 2001-05-25 2002-12-05 Ssp Co., Ltd. Medicinal compositions
JP2004210750A (ja) * 2003-01-08 2004-07-29 Nitto Yakuhin Kogyo Kk 生体リズム応用キット

Also Published As

Publication number Publication date
AR051145A1 (es) 2006-12-20
PT1807068E (pt) 2010-04-19
US20070298096A1 (en) 2007-12-27
EP1807068B1 (en) 2010-03-17
BRPI0520000A2 (pt) 2009-04-07
PE20061125A1 (es) 2006-11-08
AU2005302618A1 (en) 2006-05-11
RU2007119641A (ru) 2008-12-10
RU2398571C2 (ru) 2010-09-10
EP1807068A1 (en) 2007-07-18
ATE460930T1 (de) 2010-04-15
WO2006049978A1 (en) 2006-05-11
MX2007005121A (es) 2007-06-22
CA2583517A1 (en) 2006-05-11
AU2005302618B2 (en) 2009-10-22
CA2583517C (en) 2013-06-04
CN101048155A (zh) 2007-10-03
PL1807068T3 (pl) 2010-08-31
DE602005020048D1 (de) 2010-04-29
NO20072255L (no) 2007-07-18

Similar Documents

Publication Publication Date Title
KR880001090B1 (ko) 디피리다몰의 경구용 제형의 제조방법
US7741374B1 (en) Methods of use of fenofibric acid
JP4791348B2 (ja) 有効成分の混合物を含む組成物および調製の方法
JPH0122245B2 (cg-RX-API-DMAC10.html)
EP0312581A1 (en) PHARMACEUTICAL MATRIX WITH DELAYED RELEASE AND METHOD.
US20130296385A1 (en) Fast Dissolving Tablet
IE882286L (en) Oral sustrained release acetaminophen formulation and process
JPS62106011A (ja) 徐放性錠剤
JPH07558B2 (ja) モピダモール製剤
JPH08503482A (ja) 部分水素添加植物油で被覆されたシメチジン顆粒剤
CZ332598A3 (cs) Pevná dávková forma cisapridu
WO2014104929A1 (ru) Фармацевтическая композиция для лечения вич-инфекции
WO2004060354A1 (en) Methods for making pharmaceutical dosage forms containing active cushioning components
WO1996031218A1 (en) Pharmaceutical composition containing sucralfate
CA2583517C (en) Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkaline agent for enhanced absorption
CA2350519C (en) Chromone enteric release formulation
RU2694056C2 (ru) Противотуберкулезная стабильная фармацевтическая композиция в форме диспергируемой таблетки, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления
JPH08333259A (ja) スクラルファート含有製剤組成物
US6998139B2 (en) Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness
EP1420766A1 (en) Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers
EP1830814A2 (en) Taste masking system for non-plasticizing drugs
UA81335C2 (uk) Оральна дозована форма саквінавіру мезилату
HK1135612B (en) Taste masking system for non-plasticizing drugs

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081015

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120508